Assertion: negative breast cancer | /r/HasProperty | tnbc
Facets:
Source sentences:
text: Triple-negative breast cancer (TNBC)
text: Triple-negative breast cancer (TNBC) accounts for about 10-15% of all breast cancers.
text: Since triple-negative breast cancers (TNBC) cannot be treated with hormone therapy or targeted therapy such as HER2 drugs, the treatment options are limited to chemotherapy.
text: Five-year survival rates tend to be lower for women diagnosed with triple-negative breast cancer (TNBC).
text: Triple-negative breast cancer (TNBC) is considered an aggressive cancer because it grows quickly, is more likely to have spread at the time it’s found and is more likely to come back after treatment than other types of breast cancer.
text: Triple-negative breast cancers (TNBC) don’t have estrogen or progesterone receptors and also don’t make too much of the HER2 protein.
text: Triple-negative breast cancers (TNBC) are sometimes classified into "basal-type" and other cancers; however, there is no standard classification scheme.
text: Triple-negative breast cancers (TNBC) have, on average, significantly higher fluorine-18 fluorodeoxyglucose (FDG) uptake (measured by the SUVmax values) compared with uptake in ER+/PR+/HER2- tumors using fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET).
text: Triple-negative breast cancer (TNBC) is a type of breast cancer.